IE32197L - Pharmceutical composition - Google Patents
Pharmceutical compositionInfo
- Publication number
- IE32197L IE32197L IE83968A IE83968A IE32197L IE 32197 L IE32197 L IE 32197L IE 83968 A IE83968 A IE 83968A IE 83968 A IE83968 A IE 83968A IE 32197 L IE32197 L IE 32197L
- Authority
- IE
- Ireland
- Prior art keywords
- silver
- heavy metal
- july
- compositions
- metal salt
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 229910001385 heavy metal Inorganic materials 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 2
- 150000003378 silver Chemical class 0.000 abstract 2
- PIXHDBIHFREHSJ-UHFFFAOYSA-N 1,1-dioxo-2H-1lambda6,2,3-benzothiadiazine-4-sulfonamide Chemical class S(N)(=O)(=O)C1=NNS(C2=C1C=CC=C2)(=O)=O PIXHDBIHFREHSJ-UHFFFAOYSA-N 0.000 abstract 1
- NHZLNPMOSADWGC-UHFFFAOYSA-N 4-amino-N-(2-quinoxalinyl)benzenesulfonamide Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CN=C(C=CC=C2)C2=N1 NHZLNPMOSADWGC-UHFFFAOYSA-N 0.000 abstract 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical class NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical class N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000004098 Tetracycline Chemical class 0.000 abstract 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 abstract 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- RRDRHWJDBOGQHN-JWCTVYNTSA-N [2-[(2s,5r,8s,11s,14r,17s,22s)-17-[(1r)-1-hydroxyethyl]-22-[[(2s)-2-[[(2s,3r)-3-hydroxy-2-[[(2s)-2-[6-methyloctanoyl(sulfomethyl)amino]-4-(sulfomethylamino)butanoyl]amino]butyl]amino]-4-(sulfomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15 Chemical class CCC(C)CCCCC(=O)N(CS(O)(=O)=O)[C@@H](CCNCS(O)(=O)=O)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCNCS(O)(=O)=O)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CCNCS(O)(=O)=O)NC(=O)[C@H](CCNCS(O)(=O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(O)(=O)=O)NC1=O RRDRHWJDBOGQHN-JWCTVYNTSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229960000603 cefalotin Drugs 0.000 abstract 1
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical class [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 abstract 1
- 229940108538 colistimethate Drugs 0.000 abstract 1
- 108700028201 colistinmethanesulfonic acid Chemical class 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052737 gold Inorganic materials 0.000 abstract 1
- 239000010931 gold Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 abstract 1
- 229910052753 mercury Inorganic materials 0.000 abstract 1
- 229910052750 molybdenum Inorganic materials 0.000 abstract 1
- 239000011733 molybdenum Substances 0.000 abstract 1
- 229910052759 nickel Inorganic materials 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 229910052762 osmium Inorganic materials 0.000 abstract 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 239000004332 silver Substances 0.000 abstract 1
- NBYLLBXLDOPANK-UHFFFAOYSA-M silver 2-carboxyphenolate hydrate Chemical compound C1=CC=C(C(=C1)C(=O)O)[O-].O.[Ag+] NBYLLBXLDOPANK-UHFFFAOYSA-M 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 229960002597 sulfamerazine Drugs 0.000 abstract 1
- QPPBRPIAZZHUNT-UHFFFAOYSA-N sulfamerazine Chemical class CC1=CC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 QPPBRPIAZZHUNT-UHFFFAOYSA-N 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- GECHUMIMRBOMGK-UHFFFAOYSA-N sulfapyridine Chemical class C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=CC=N1 GECHUMIMRBOMGK-UHFFFAOYSA-N 0.000 abstract 1
- 229960002211 sulfapyridine Drugs 0.000 abstract 1
- 229960001544 sulfathiazole Drugs 0.000 abstract 1
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical class C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 150000003456 sulfonamides Chemical class 0.000 abstract 1
- -1 sulphonanilide Chemical class 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Chemical class 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 239000011135 tin Substances 0.000 abstract 1
- 229910052718 tin Inorganic materials 0.000 abstract 1
- 229910052719 titanium Inorganic materials 0.000 abstract 1
- 239000010936 titanium Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1,240,546. Medicines containing antibiotics and sulphonamides. RESEARCH CORP. 16 July, 1968 [17 July, 1967], No. 49459/70. Divided out of 1,240,545. Heading A5B. A pharmaceutical composition comprises a heavy metal salt of an antibiotic in admixture with a heavy metal salt of a sulphonamide and/or silver salicylate. The heavy metal salts may be those of gold, nickel, tin, zinc, mercury, platinum, osmium, molybdenum, titanium, copper or silver (preferred). Specified are silver salts of penicillin, cephalothin, colistimethate, and tetracycline; and silver salts of sulphamerazine, sulphonanilide, sulphathiazole, sulphapyridine, sulphamylon, sulphoxazole, sulphapyrimidine, sulphaquinoxaline, substituted benzene sulphonamide and sulphamyl benzothiadiazine dioxide. The compositions may be in the form of a powder, an aqueous suspension, ointment, aerosol or may be incorporated in a film-forming material. Aqueous solutions containing chloride ions e.g. NaCl may be used as carriers for the active ingredients. Specification 1,240,545 is referred to. The compositions are useful in the treatment of burns.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE426/72A IE32198B1 (en) | 1967-07-17 | 1968-07-15 | Improvements in or relating to antibacterial compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65383067A | 1967-07-17 | 1967-07-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE32197L true IE32197L (en) | 1969-01-17 |
| IE32197B1 IE32197B1 (en) | 1973-05-16 |
Family
ID=24622450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE83968A IE32197B1 (en) | 1967-07-17 | 1968-07-15 | Silver-containing therapeutic agents |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE718183A (en) |
| DE (1) | DE1792053B1 (en) |
| ES (1) | ES356142A1 (en) |
| FR (2) | FR1586125A (en) |
| GB (2) | GB1240545A (en) |
| IE (1) | IE32197B1 (en) |
| NL (1) | NL6809794A (en) |
| PH (1) | PH10639A (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4049802A (en) | 1975-03-19 | 1977-09-20 | Research Corporation | Zinc sulfadiazine and its use in the treatment of burns |
| DE2804931A1 (en) * | 1978-02-06 | 1979-08-16 | Fresenius Chem Pharm Ind | METAL SULFADIAZINE IN FINE PARTICULAR FORM |
| US4384117A (en) * | 1980-03-18 | 1983-05-17 | The United States Of America As Represented By The Secretary Of The Army | Silver metachloridine |
| AU1388388A (en) * | 1987-04-01 | 1988-10-06 | Dak-Laboratoriet A/S | Benzoic acid derivatives and use thereof |
| CA2024220A1 (en) * | 1990-08-29 | 1992-03-01 | Don Simmons | Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
| IT1243435B (en) * | 1990-10-05 | 1994-06-10 | Altergon Sa | PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE INCLUDING HYALURONIC ACID SODIUM SALT AND DISINFECTANT SUBSTANCES |
| EA200400708A1 (en) | 2001-11-22 | 2004-10-28 | Биовитрум Аб | INHIBITORS 11-BETA-HYDROXYSTEROID DEGYDROGENASE TYPE 1 |
| US7173030B2 (en) | 2003-05-21 | 2007-02-06 | Biovitrum Ab | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| EP1631558A1 (en) * | 2003-05-21 | 2006-03-08 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| SE0301882D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use I |
| SE0301888D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use VII |
| SE0301886D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use V |
| WO2004113310A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
| SE0301884D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use III |
| SE0301885D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use IV |
| BRPI1104620B1 (en) * | 2011-09-09 | 2020-04-07 | Lucia Teixeira De Carvalho | pharmaceutical composition for the treatment of burns and skin lesions and their preparation process |
-
1968
- 1968-07-05 PH PH9358A patent/PH10639A/en unknown
- 1968-07-10 NL NL6809794A patent/NL6809794A/xx unknown
- 1968-07-13 ES ES356142A patent/ES356142A1/en not_active Expired
- 1968-07-15 IE IE83968A patent/IE32197B1/en unknown
- 1968-07-16 GB GB33831/68A patent/GB1240545A/en not_active Expired
- 1968-07-16 FR FR1586125D patent/FR1586125A/fr not_active Expired
- 1968-07-16 GB GB4945970A patent/GB1240546A/en not_active Expired
- 1968-07-17 DE DE19681792053 patent/DE1792053B1/en active Pending
- 1968-07-17 BE BE718183D patent/BE718183A/xx not_active IP Right Cessation
- 1968-10-11 FR FR169591A patent/FR8146M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES356142A1 (en) | 1970-02-16 |
| IE32197B1 (en) | 1973-05-16 |
| GB1240546A (en) | 1971-07-28 |
| FR1586125A (en) | 1970-02-13 |
| PH10639A (en) | 1977-07-22 |
| NL6809794A (en) | 1969-01-21 |
| FR8146M (en) | 1970-08-17 |
| DE1792053B1 (en) | 1971-07-29 |
| GB1240545A (en) | 1971-07-28 |
| BE718183A (en) | 1969-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR8146M (en) | ||
| GB1385086A (en) | Insulin product | |
| ES485065A1 (en) | Amino or acylamino-substituted pyrimidinyl cephalosporanic acid derivatives and pharmaceutical compositions thereof | |
| GB1397073A (en) | 1,2,4-oxadizoles | |
| GB1318478A (en) | Cephalexin salts | |
| GB1442772A (en) | Inhibition of leukaemia utilizing 5-methyl-tetrahydrohomofolate | |
| GB1419121A (en) | Heterocyclic-fused triazole derivatives and their use in controlling plant pathogenic organisms | |
| GB1361198A (en) | Disulphide compounds and process for their manufa'ture | |
| GB1252286A (en) | ||
| GB1350878A (en) | Coumarin derivatives and production thereof | |
| GB1482651A (en) | Pharmaceutical products | |
| GB1132583A (en) | Pharmaceutical compositions containing cephalosporins | |
| GB1512604A (en) | Pharmaceutical compositions | |
| GB1276061A (en) | Tetronic acid derivatives, process for the manufacture thereof, and compositions containing such compounds | |
| GB1314899A (en) | Thiosemicarbazones processes for their preparations and compositions incorporating them | |
| GB1134985A (en) | 2-halo-1,1,3,3-tetrafluoropropanes | |
| GB1324750A (en) | Diacetate pharmaceutical preparations and manufacturing processes | |
| GB1252373A (en) | ||
| GB1381072A (en) | 3-amino-as-triazino-6,5-quinoline and derivatives | |
| GB1466857A (en) | Urea tablets | |
| GB1287433A (en) | Pharmaceutical compositions | |
| GB994350A (en) | Improvements in or relating to pteridine compounds and processes for their preparation | |
| GB1175590A (en) | Therapeutic Compositions | |
| GB1509778A (en) | Pharmaceutical composition and dosage units thereof | |
| GB1230906A (en) |